ABACAVIR 60 MG (AS ABACAVIR SULFATE 70.2 MG) / DOLUTEGRAVIR 5 MG (AS DOLUTEGRAVIR SODIUM 5.26 MG) / LAMIVUDINE 30 MG TABLET FOR ORAL SUSPENSION [TRIUMEQ]

Side Effects & Adverse Event Reports


View Chart Data

25K

Adverse Events

97.1K

Side Effects

2010

Data Starting In

SymPedia Mobile App

Get our Mobile App for easy access to the latest reports on ABACAVIR 60 MG (AS ABACAVIR SULFATE 70.2 MG) / DOLUTEGRAVIR 5 MG (AS DOLUTEGRAVIR SODIUM 5.26 MG) / LAMIVUDINE 30 MG TABLET FOR ORAL SUSPENSION [TRIUMEQ].

Understanding the potential Side Effects and Adverse Events of ABACAVIR 60 MG (AS ABACAVIR SULFATE 70.2 MG) / DOLUTEGRAVIR 5 MG (AS DOLUTEGRAVIR SODIUM 5.26 MG) / LAMIVUDINE 30 MG TABLET FOR ORAL SUSPENSION [TRIUMEQ] is essential for making informed health decisions. Our application provides in-depth reports based on real-world data, helping you explore how ABACAVIR 60 MG (AS ABACAVIR SULFATE 70.2 MG) / DOLUTEGRAVIR 5 MG (AS DOLUTEGRAVIR SODIUM 5.26 MG) / LAMIVUDINE 30 MG TABLET FOR ORAL SUSPENSION [TRIUMEQ] may affect your health.

View reports containing much more information including:

  • Age group - See how different age ranges experience side effects and adverse reactions.
  • Year - Track trends over time to understand changes in reported issues.
  • Biological sex - Compare how reports vary between men and women.
  • Weight - Examine the impact of body weight on side effects and adverse events.
Download Now

Frequently Asked Questions

Some questions about ABACAVIR 60 MG (AS ABACAVIR SULFATE 70.2 MG) / DOLUTEGRAVIR 5 MG (AS DOLUTEGRAVIR SODIUM 5.26 MG) / LAMIVUDINE 30 MG TABLET FOR ORAL SUSPENSION [TRIUMEQ] are asked frequently. We've answered the most frequent of those questions below

  • How many adverse events have been reported for ABACAVIR 60 MG (AS ABACAVIR SULFATE 70.2 MG) / DOLUTEGRAVIR 5 MG (AS DOLUTEGRAVIR SODIUM 5.26 MG) / LAMIVUDINE 30 MG TABLET FOR ORAL SUSPENSION [TRIUMEQ]?

    SymPedia shows ABACAVIR 60 MG (AS ABACAVIR SULFATE 70.2 MG) / DOLUTEGRAVIR 5 MG (AS DOLUTEGRAVIR SODIUM 5.26 MG) / LAMIVUDINE 30 MG TABLET FOR ORAL SUSPENSION [TRIUMEQ] adverse event reports for 25,015.

  • How many side effects have been reported for ABACAVIR 60 MG (AS ABACAVIR SULFATE 70.2 MG) / DOLUTEGRAVIR 5 MG (AS DOLUTEGRAVIR SODIUM 5.26 MG) / LAMIVUDINE 30 MG TABLET FOR ORAL SUSPENSION [TRIUMEQ]?

    SymPedia shows ABACAVIR 60 MG (AS ABACAVIR SULFATE 70.2 MG) / DOLUTEGRAVIR 5 MG (AS DOLUTEGRAVIR SODIUM 5.26 MG) / LAMIVUDINE 30 MG TABLET FOR ORAL SUSPENSION [TRIUMEQ] side effect reports for 97,128.

  • What year does the ABACAVIR 60 MG (AS ABACAVIR SULFATE 70.2 MG) / DOLUTEGRAVIR 5 MG (AS DOLUTEGRAVIR SODIUM 5.26 MG) / LAMIVUDINE 30 MG TABLET FOR ORAL SUSPENSION [TRIUMEQ] reporting data start?

    SymPedia reporting data on this page starts in 2010.

  • What years are included in the yearly chart for ABACAVIR 60 MG (AS ABACAVIR SULFATE 70.2 MG) / DOLUTEGRAVIR 5 MG (AS DOLUTEGRAVIR SODIUM 5.26 MG) / LAMIVUDINE 30 MG TABLET FOR ORAL SUSPENSION [TRIUMEQ]?

    SymPedia yearly chart data on this page covers 2010 to 2912.